The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
about
Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic reviewClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIPseudophakic cystoid macular edema: update 2016Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a reviewPseudophakic cystoid macular edema associated with extrafoveal vitreoretinal traction.Etiology and treatment of the inflammatory causes of cystoid macular edema.Transient corneal edema is a predictive factor for pseudophakic cystoid macular edema after uncomplicated cataract surgery.Chronic cystoid macular oedema treated with intravitreal dobesilate.Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single siteLoteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review.Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population.Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification.Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%.Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trialLoteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.Topical nonsteroidal anti-inflammatory drugs for macular edema.Cataract surgery and nonsteroidal antiinflammatory drugs.Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate.Diabetic cataract-pathogenesis, epidemiology and treatment.Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac.Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.Pathophysiology of transient corneal edema and pseudophakic cystoid macular edema.Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series.Long-term follow-up after scleral lens fixation in patients with Marfan syndrome.The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification.RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE.Anterior chamber lens implantation in vitrectomised eyes.New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors.
P2860
Q24596891-E2A3E91D-2407-4937-90C4-C64942DD1D6BQ26864721-470E70DF-506A-4868-B454-1D4FE20D0589Q28076636-76755D9F-8A62-4F95-A1FE-A07966D96419Q28077419-FAEE39F6-7074-4E94-A38E-918387E30B6DQ30500692-40F6CDC9-E38A-45C0-A89E-73FC2D3C084BQ34077613-4E0E6F9C-A8AD-4520-9238-98387EB12829Q35024530-16F51A2B-E99E-42D8-B88F-9E786CFBDCD3Q35977226-45BA1E03-A95D-4C0E-9B38-722BE068546CQ36102155-ED3EF7D4-7AE9-4CAD-98A0-62DE9850DDFBQ36145683-42C61D37-EA3A-4DCD-BBA0-3FE2B1181BDCQ36173245-8E319BCC-5551-49C3-B7C2-92757894EC3CQ36290231-3A55AD35-6D6F-46DF-B17C-AF6FEA8C6370Q36525799-669FB57E-9C2E-4162-8237-78281BCF0904Q36832291-626770F7-38E3-4D18-982D-E073D16CC508Q37577432-27061271-5F5B-47F0-8693-7E405ACB748DQ37577437-34AEAE0F-8EFB-490F-B6C2-5CB13E7F6B5EQ37695091-B4546FFE-F95C-4590-81EE-B770DFCAE9FDQ38019465-97FBE605-817A-46D2-8BB9-732DC400949CQ38162433-FF0ABC74-F191-4F85-8660-25F7064BA072Q38970979-1E945A8D-8F82-48CE-BABC-3884518E5294Q40703915-B081B871-6491-4B46-A116-9AA00ADA0594Q41776952-3BBBE1A6-FBE5-4FEF-BEF3-970D1DB4B05AQ42014765-4751A498-AF1B-4AAA-8885-4B052B21FFBDQ42125064-7D6503E5-1690-41CE-83FA-7099EF963906Q42262074-31E1DC8F-1929-4730-B6ED-E037B19B38D9Q42948008-F7BDF9EA-CFE5-4874-9373-C20AEFEE78BAQ45121803-E91C69EC-0ABE-4C49-AD85-DA82DB29290CQ47281498-69972535-008B-4BA7-B421-56BBD306CEDFQ48246916-E97D3F30-6CA9-4CE3-858D-3D364DAD6490Q49965944-3B3FF2A5-FCE1-4AB9-8E0B-F3102F0400C5Q50006033-28CEA2B8-C8DC-4F10-BE95-001D289CD68AQ52593842-08D3F3BC-5EC5-4F57-B62A-48C2AF43A1EB
P2860
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The incidence, pathogenesis an ...... ma following cataract surgery.
@ast
The incidence, pathogenesis an ...... ma following cataract surgery.
@en
type
label
The incidence, pathogenesis an ...... ma following cataract surgery.
@ast
The incidence, pathogenesis an ...... ma following cataract surgery.
@en
prefLabel
The incidence, pathogenesis an ...... ma following cataract surgery.
@ast
The incidence, pathogenesis an ...... ma following cataract surgery.
@en
P2860
P1476
The incidence, pathogenesis an ...... ema following cataract surgery
@en
P2093
P2860
P304
P577
1998-01-01T00:00:00Z